As nations race to develop treatments and vaccines for COVID-19, Japan has become a victim of its own success as slowing new infections has led to a shortage of patients to enroll in clinical trials. Clinical trials are underway for more than a dozen potential vaccines, including at least six in China, but Japan’s first […]
from Daily Times https://ift.tt/3hXSJOv
No comments:
Post a Comment